Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SWI: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | SWI |
| Key Genes/Proteins | ADNP, ASC, ATG, BACE1, BECN1, BRG1 |
| Related Diseases | autism spectrum disorder, cancer |
| Related Pathways | autophagy pathway |
| Linked Hypotheses | 1 hypotheses |
Knowledge base pages for this entity
graph TD
SWI[SWI]
SWI -->|activates| TNF[TNF]
SWI -->|activates| TNFA[TNFA]
SWI -->|activates| ULK1[ULK1]
SWI -->|activates| cancer[cancer]
SWI -->|causes| VHL[VHL]
SWI -->|participates in| autophagy_pathway[autophagy pathway]
SWI -->|participates in| oxidative_stress_response[oxidative stress response]
SWI -->|participates in| necroptosis[necroptosis]
SWI -->|participates in| MAPK_signaling[MAPK signaling]
SNF[SNF] -->|interacts| SWI
ASC[ASC] -->|activates| SWI
BECN1[BECN1] -->|activates| SWI
BRG1[BRG1] -->|activates| SWI
CLDN2[CLDN2] -->|activates| SWI
ERN1[ERN1] -->|activates| SWI
IRGM1[IRGM1] -->|activates| SWI
LC3[LC3] -->|activates| SWI
MELK[MELK] -->|activates| SWI
MTOR[MTOR] -->|activates| SWI| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:SWI | data_in | dataset_row | 0.00 |
| TNFA | activates | gene | 0.60 |
| ULK1 | activates | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| autism spectrum disorder | interacts_with | disease | 0.60 |
| cancer | causes | disease | 0.60 |
| cancer | activates | disease | 0.60 |
| autophagy pathway | participates_in | pathway | 0.60 |
| oxidative stress response | participates_in | pathway | 0.60 |
| necroptosis | participates_in | pathway | 0.60 |
| MAPK signaling | participates_in | pathway | 0.60 |
| PI3K-AKT-mTOR signaling | participates_in | pathway | 0.60 |
| VHL | causes | gene | 0.60 |
| stem cells | expressed_in | cell_type | 0.55 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:SWI | data_in | dataset_row | 0.00 |
| SNF | interacts_with | gene | 0.70 |
| ROS | activates | gene | 0.60 |
| BACE1 | associated_with | gene | 0.60 |
| SNF | causes | gene | 0.60 |
| SNF | targets | gene | 0.60 |
| ATG | activates | gene | 0.60 |
| CCDC50 | activates | gene | 0.60 |
| IKK | activates | gene | 0.60 |
| MAP1LC3 | activates | gene | 0.60 |
| NLR | activates | gene | 0.60 |
| NRBF2 | activates | gene | 0.60 |
| rapamycin | targets | drug | 0.60 |
| MAPK | activates | gene | 0.60 |
| PBRM1 | causes | gene | 0.60 |
| ASC | activates | gene | 0.60 |
| BECN1 | activates | gene | 0.60 |
| BRG1 | activates | gene | 0.60 |
| CLDN2 | activates | gene | 0.60 |
| ERN1 | activates | gene | 0.60 |
| IRGM1 | activates | gene | 0.60 |
| LC3 | activates | gene | 0.60 |
| MELK | activates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| NLRP3 | activates | gene | 0.60 |
| NOD2 | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| PYCARD | activates | gene | 0.60 |
| RALGAPA2 | activates | gene | 0.60 |
| RIPK2 | activates | gene | 0.60 |
| RIPK3 | activates | gene | 0.60 |
| SMARCA4 | activates | gene | 0.60 |
| SNF | activates | gene | 0.60 |
| SQSTM1 | activates | gene | 0.60 |
| STAT3 | activates | gene | 0.60 |
| ADNP | interacts_with | gene | 0.60 |
| RAPAMYCIN | associated_with | drug | 0.45 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| ABCA1 rs2230806 polymorphism association with dementia risk in hyperli | exploratory | dementia, Alzheimer's disease | 0.900 | 0.00 | human patients | proposed | N/A |
| Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $100,000 |
| Proposed experiment from debate on Microglia activate astrocytes via I | falsification | Neuroinflammation | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| Metabolic Pathway-Targeted Therapy in ALS | clinical | ALS | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neur | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Cytochrome Therapeutics | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Peroxisomal Dysfunction Validation in Parkinson's Disease | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $2,280,000 |
| Peroxisome Dysfunction Validation in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| HK1 and HK2 Beyond Glycolysis: Mitochondrial Interactions and Dual Roles in Meta [PMID:41387352] | Pesce NA, Seminara G, Giarrusso G, Tomas | Adv Biol (Weinh) | 2026 | 1 |
| Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative [PMID:39987285] | Fang M, Zhou Y, He K, Lu Y, Tao F, Huang | Mol Neurobiol | 2025 | 1 |
| Hexokinase 2-mediated metabolic stress and inflammation burden of liver macropha [PMID:40014451] | Li J, Chen X, Song S, Jiang W, Geng T, W | Cell Rep | 2025 | 1 |
| The PI3K/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer. [PMID:38904014] | Fontana F, Giannitti G, Marchesi S, Limo | Int J Biol Sci | 2024 | 1 |
| Inhibition of sterol O-acyltransferase 1 blocks Zika virus infection in cell lin [PMID:39237833] | Schöbel A, Pinho Dos Reis V, Burkhard R, | Commun Biol | 2024 | 1 |
| Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage. [PMID:36009491] | Kou Y, Geng F, Guo D | Biomedicines | 2022 | 1 |
| Lipid Stores and Lipid Metabolism Associated Gene Expression in Porcine and Bovi [PMID:32899450] | Kajdasz A, Warzych E, Derebecka N, Madej | Int J Mol Sci | 2020 | 1 |
| Metabolic phenotype of bladder cancer. [PMID:26975021] | Massari F, Ciccarese C, Santoni M, Iacov | Cancer Treat Rev | 2016 | 1 |
| Inducible deletion of DGAT1 and 2 from microglia exacerbates neurodegeneration a [PMID:41546868] | ["Tabor G", "Litvinchuk A", "Chen Y", "A | Cell reports | 2026 | 0 |
| Neuroprotective Effects of Berberine Chloride Against the Aluminium Chloride-Ind [PMID:40014257] | Uvarajan D, Gnanarajan R, Karuppusamy PA | Mol Biotechnol | 2026 | 0 |
| Aryl hydrocarbon receptor impairs HK2-controlled flux of the hexosamine biosynth [PMID:40582563] | Li S, Zhu J, Song J, Yang L, Gong Y et a | J Adv Res | 2026 | 0 |
| Changes in Circulating Levels of miR-30b During Minipuberty and Puberty in Girls [PMID:40899010] | Albrechtsen HM, Saritas G, Winge SB, Mai | J Clin Endocrinol Metab | 2026 | 0 |
| HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis [PMID:41023273] | Mitchell CD, Morris CA, Wild M, Cunningh | Acta Pharmacol Sin | 2026 | 0 |
| Hypoxia-Induced Histone Lactylation Promotes Ferroptosis in Cardiomyocytes via t [PMID:41229334] | Zhu XH, Hou JW, Lv ZY, Sun MH, Zhang XY | Kaohsiung J Med Sci | 2026 | 0 |
| Epigenetics in chronic rhinosinusitis. [PMID:41442742] | Kumar N, Brar T, Lal D | Curr Opin Otolaryngol Head Nec | 2026 | 0 |
| Granzyme B knockdown inhibits NLRP3-mediated pyroptosis and the JAK2/STAT3 signa [PMID:41447776] | Wang M, Chen D, Zhang D, Han H, Xie M et | Tissue Cell | 2026 | 0 |
| Multimodal Antiatherosclerotic Effects of Clinical-Grade Mesenchymal Stem Cell-D [PMID:41503702] | Kim J, Park D, Yoo J, Kim JE, Kim EH et | Stroke | 2026 | 0 |
| Targeting glycolysis in prostate cancer: Molecular mechanisms and therapeutic ad [PMID:41548699] | Zhang J, Zhang T, Song D, Xu D | Biochim Biophys Acta Rev Cance | 2026 | 0 |
| Interplay between cholesterol, Bis(monoacylglycerol)phosphate, and parasitophoro [PMID:41747887] | Hennot C, Leroux M, Lambert R, Boukherro | Biochimie | 2026 | 0 |
| Integrated Bioinformatics Analysis of a TF-miRNA-mRNA Regulatory Network in Reti [PMID:41755728] | Liang C, Xie H, Shi Q, Diao Y, Yu G et a | Curr Eye Res | 2026 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning SWI in their description or question text
Score: 0.708 · synaptic biology · 2026-04-21
## Mechanistic Overview TREM2-Dependent Switch Hypothesis: TREM2 Agonism Redirects SPP1 Signaling from Destructive to Re
Score: 0.700 · neurodegeneration · 2026-04-22
**Molecular Mechanism and Rationale** The triggering receptor expressed on myeloid cells 2 (TREM2) functions as a criti
Score: 0.695 · unknown disease · 2026-04-04
## Mechanistic Overview Temporal Microglial State Switching starts from the claim that modulating Optogenetic constructs
Score: 0.689 · neurodegeneration · 2026-04-17
## Mechanistic Overview Endothelial NRF2 Activation as a Master Switch for Post-CA BBB Protection starts from the claim
Score: 0.666 · neurodegeneration · 2026-04-02
## Mechanistic Overview Lipid Droplet Dynamics as Phenotype Switches starts from the claim that modulating DGAT1 and SOA
Score: 0.665 · neurodegeneration · 2026-04-02
## Mechanistic Overview Complement C1q Subtype Switching starts from the claim that modulating C1QA within the disease c
Score: 0.664 · neurodegeneration · 2026-04-13
**Molecular Mechanism and Rationale** The stathmin-2 splice switching therapeutic approach targets a fundamental pathom
Score: 0.625 · neurodegeneration · 2026-04-22
## Mechanistic Overview H7: Aberrant RNA Template Switching Converts Granules to Aggregation Prone starts from the claim
Score: 0.624 · neurodegeneration · 2026-04-04
## Mechanistic Overview Conditional CRISPR Kill Switches for Aberrant Protein Clearance starts from the claim that modul
Score: 0.609 · neurodegeneration · 2026-04-16
## Mechanistic Overview Ketone-Based Metabolic Switching to Restore PV Interneuron Function starts from the claim that m
Score: 0.607 · neurodegeneration · 2026-04-21
## Mechanistic Overview Calmodulin isoform switching from CaMK to calcineurin activation upon lysosomal permeabilization
Score: 0.577 · neurodegeneration · 2026-04-20
**Molecular Mechanism and Rationale** The molecular foundation of this biomarker panel centers on the intricate interpl
Score: 0.570 · neurodegeneration · 2026-04-25
REST Complex Dysregulation as Master Epigenetic Switch
Score: 0.531 · metabolic neuroscience · 2026-04-16
## Mechanistic Overview Glucose-Ketone Metabolic Switch Timing starts from the claim that modulating GLUT1/GLUT3/MCT1/MC
Score: 0.530 · neurodegeneration · 2026-04-25
Polycomb-to-Trithorax Switch at Synaptic Plasticity Genes